Alzheimer's Disease Neuroimaging Initiative
GPTKB entity
Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
research
|
| gptkbp:abbreviation |
ADNI
|
| gptkbp:collaboratesWith |
hospitals
industry partners universities |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:dataCollected |
researchers worldwide
|
| gptkbp:focus |
gptkb:Alzheimer's_disease
|
| gptkbp:fundedBy |
gptkb:National_Institutes_of_Health
non-profit organizations pharmaceutical companies |
| gptkbp:goal |
identify biomarkers for Alzheimer's disease
improve clinical trials for Alzheimer's disease |
| https://www.w3.org/2000/01/rdf-schema#label |
Alzheimer's Disease Neuroimaging Initiative
|
| gptkbp:principalInvestigator |
Michael W. Weiner
|
| gptkbp:startDate |
2004
|
| gptkbp:studies |
cognitive decline
healthy aging mild cognitive impairment early Alzheimer's disease |
| gptkbp:type |
longitudinal data
biomarker data clinical assessments multimodal imaging |
| gptkbp:uses |
gptkb:PET_scans
genetic data MRI cerebrospinal fluid analysis |
| gptkbp:website |
http://adni.loni.usc.edu/
|
| gptkbp:bfsParent |
gptkb:Quanterix_Corporation
|
| gptkbp:bfsLayer |
8
|